| Results summary | View all lists in L2L MDB | View all genes in L01X.profile.u50 |
|
Reduced expression in XPC-defective fibroblasts, compared to normal fibroblasts, following treatment with cisplatin enrichment: 5.57-fold |
![]() |
||||||||||||
| Probe ID | Name | G | T | D | X | E | P | R | C | S | Description | ||
| 208763_S_AT | TSC22D3 | R | TSC22 domain family, member 3 | ||||||||||
| 203140_AT | BCL6 | G | D | X | R | C | S | B-cell CLL/lymphoma 6 (zinc finger protein 51) | |||||
| 207419_S_AT | RAC2 | S | ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) | ||||||||||
| 203725_AT | GADD45A | G | X | growth arrest and DNA-damage-inducible, alpha | |||||||||
| 216080_S_AT | FADS3 | E | fatty acid desaturase 3 | ||||||||||